CytomX Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2013 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
CytomX Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2024.
  • CytomX Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was $17.7M.
  • CytomX Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was $25M.
  • CytomX Therapeutics, Inc. annual Operating Income (Loss) for 2024 was $25M.
  • CytomX Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$6.48M, a 93.6% increase from 2022.
  • CytomX Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$101M, a 12.7% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $25M +$31.5M Jan 1, 2024 Dec 31, 2024 10-K 2025-03-06
2023 -$6.48M +$94.9M +93.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-06
2022 -$101M +$14.7M +12.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-11
2021 -$116M -$35.5M -44.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 -$80.5M +$60.9M +43.1% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-03-27
2019 -$141M -$63.6M -81.7% Jan 1, 2019 Dec 31, 2019 10-K/A 2023-03-27
2018 -$77.9M -$31.6M -68.3% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 -$46.3M +$13.3M +22.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 -$59.6M -$26.4M -79.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 -$33.2M -$3.44M -11.6% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
2014 -$29.8M -$14.8M -99% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-02
2013 -$15M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.